Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2010 (2010), Article ID 410278, 10 pages
http://dx.doi.org/10.1155/2010/410278
Research Article

Superficial Dsg2 Expression Limits Epidermal Blister Formation Mediated by Pemphigus Foliaceus Antibodies and Exfoliative Toxins

Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA

Received 11 January 2010; Revised 23 February 2010; Accepted 10 March 2010

Academic Editor: Peter J. Koch

Copyright © 2010 Donna Brennan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Cheng and P. J. Koch, “In vivo function of desmosomes,” Journal of Dermatology, vol. 31, no. 3, pp. 171–187, 2004. View at Google Scholar · View at Scopus
  2. M. G. Mahoney, Y. Hu, D. Brennan, H. Bazzi, A. M. Christiano, and J. K. Wahl III, “Delineation of diversified desmoglein distribution in stratified squamous epithelia: implications in diseases,” Experimental Dermatology, vol. 15, no. 2, pp. 101–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. S. Payne, Y. Hanakawa, M. Amagai, and J. R. Stanley, “Desmosomes and disease: pemphigus and bullous impetigo,” Current Opinion in Cell Biology, vol. 16, no. 5, pp. 536–543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Stanley and M. Amagai, “Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome,” New England Journal of Medicine, vol. 355, no. 17, pp. 1800–1810, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Amagai, K. Tsunoda, D. Zillikens, T. Nagai, and T. Nishikawa, “The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile,” Journal of the American Academy of Dermatology, vol. 40, no. 2, pp. 167–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. M. G. Mahoney, Z. Wang, K. Rothenberger, P. J. Koch, M. Amagai, and J. R. Stanley, “Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris,” Journal of Clinical Investigation, vol. 103, no. 4, pp. 461–468, 1999. View at Google Scholar · View at Scopus
  7. Y. Hanakawa and J. R. Stanley, “Mechanisms of blister formation by staphylococcal toxins,” Journal of Biochemistry, vol. 136, no. 6, pp. 747–750, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Amagai, N. Matsuyoshi, Z. H. Wang, C. Andl, and J. R. Stanley, “Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1,” Nature Medicine, vol. 6, no. 11, pp. 1275–1277, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Yokouchi, M. A. Saleh, K. Kuroda et al., “Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence,” Journal of Investigative Dermatology, vol. 129, no. 9, pp. 2156–2166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Li, V. Aoki, G. Hans-Filho, E. A. Rivitti, and L. A. Diaz, “The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem),” The Journal of Experimental Medicine, vol. 197, pp. 1501–1510, 2003. View at Google Scholar
  11. M. Sekiguchi, Y. Futei, Y. Fujii, T. Iwasaki, T. Nishikawa, and M. Amagai, “Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins,” Journal of Immunology, vol. 167, no. 9, pp. 5439–5448, 2001. View at Google Scholar · View at Scopus
  12. N. A. Chitaev and S. M. Troyanovsky, “Direct Ca2+ dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion,” Journal of Cell Biology, vol. 138, no. 1, pp. 193–201, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Spindler, W.-M. Heupel, A. Efthymiadis et al., “Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus,” Journal of Biological Chemistry, vol. 284, no. 44, pp. 30556–30564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Brennan, Y. Hu, S. Joubeh et al., “Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes,” Journal of Cell Science, vol. 120, no. 5, pp. 758–771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Ota, M. Amagai, M. Watanabe, and T. Nishikawa, “No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases,” Journal of Dermatological Science, vol. 32, no. 2, pp. 137–141, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Hanakawa, N. M. Schechter, C. Lin, K. Nishifuji, M. Amagai, and J. R. Stanley, “Enzymatic and molecular characteristics of the efficiency and specificity of exfoliative toxin cleavage of desmoglein 1,” Journal of Biological Chemistry, vol. 279, no. 7, pp. 5268–5277, 2003. View at Google Scholar
  17. D. Brennan, Y. Hu, A. Kljuic et al., “Differential structural properties and expression patterns suggest functional significance for multiple mouse desmoglein 1 isoforms,” Differentiation, vol. 72, no. 8, pp. 434–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Shirakata, M. Amagai, Y. Hanakawa, T. Nishikawa, and K. Hashimoto, “Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1,” Journal of Investigative Dermatology, vol. 110, no. 1, pp. 76–78, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Wu, Z. H. Wang, A. Yan et al., “Protection against pemphigus foliaceus by desmoglein 3 in neonates,” New England Journal of Medicine, vol. 343, no. 1, pp. 31–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Hanakawa, N. Matsuyoshi, and J. R. Stanley, “Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion,” Journal of Investigative Dermatology, vol. 119, no. 1, pp. 27–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Amagai, A. R. Ahmed, Y. Kitajima et al., “Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just “witnesses of disease”?” Experimental Dermatology, vol. 15, pp. 815–831, 2006. View at Google Scholar
  22. E. Schmidt and J. Waschke, “Apoptosis in pemphigus,” Autoimmunity Reviews, vol. 8, no. 7, pp. 533–537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Waschke, P. Bruggeman, W. Baumgartner, D. Zillikens, and D. Drenckhahn, “Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction,” Journal of Clinical Investigation, vol. 115, no. 11, pp. 3157–3165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Williamson, N. A. Raess, R. Caldelari et al., “Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin,” EMBO Journal, vol. 25, no. 14, pp. 3298–3309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Ishii, Y. Maeyama, T. Karashima et al., “A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996–2006),” Clinical and Experimental Dermatology, vol. 33, no. 5, pp. 641–643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. E. Dick and V. P. Werth, “Pemphigus: a treatment update,” Autoimmunity, vol. 39, no. 7, pp. 591–599, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. O'Neill, “Targeting signal transduction as a strategy to treat inflammatory diseases,” Nature Reviews Drug Discovery, vol. 5, no. 7, pp. 549–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. G. Mahoney, Z. H. Wang, and J. R. Stanley, “Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice,” Journal of Investigative Dermatology, vol. 113, no. 1, pp. 22–25, 1999. View at Publisher · View at Google Scholar · View at Scopus